Arbutus Biopharma Corp. (ABUS)
4.28
-0.20
(-4.46%)
USD |
NASDAQ |
Oct 07, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma EPS Diluted (Quarterly) : -0.026 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.026 |
| March 31, 2026 | 0.8693 |
| December 31, 2025 | -0.0195 |
| September 30, 2025 | -0.0404 |
| June 30, 2025 | 0.0131 |
| March 31, 2025 | -0.1286 |
| December 31, 2024 | -0.066 |
| September 30, 2024 | -0.1043 |
| June 30, 2024 | -0.1053 |
| March 31, 2024 | -0.1018 |
| December 31, 2023 | -0.1147 |
| September 30, 2023 | -0.12 |
| June 30, 2023 | -0.1029 |
| March 31, 2023 | -0.1011 |
| December 31, 2022 | -0.142 |
| September 30, 2022 | -0.1163 |
| June 30, 2022 | -0.0954 |
| March 31, 2022 | -0.1062 |
| December 31, 2021 | -0.151 |
| September 30, 2021 | -0.2394 |
| June 30, 2021 | -0.2338 |
| March 31, 2021 | -0.2097 |
| December 31, 2020 | -0.2304 |
| September 30, 2020 | -0.274 |
| June 30, 2020 | -0.2454 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2488 |
| December 31, 2019 | -0.46 |
| September 30, 2019 | -1.500 |
| June 30, 2019 | -0.4591 |
| March 31, 2019 | -0.4658 |
| December 31, 2018 | -0.3764 |
| September 30, 2018 | -0.4879 |
| June 30, 2018 | 0.01 |
| March 31, 2018 | -0.36 |
| December 31, 2017 | -0.67 |
| September 30, 2017 | -0.21 |
| June 30, 2017 | -0.33 |
| March 31, 2017 | -0.34 |
| December 31, 2016 | -3.988 |
| September 30, 2016 | -0.37 |
| June 30, 2016 | -2.47 |
| March 31, 2016 | -0.31 |
| December 31, 2015 | -0.10 |
| September 30, 2015 | -0.57 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.40 |
| December 31, 2014 | -0.27 |
| September 30, 2014 | -0.39 |
| June 30, 2014 | -0.28 |
| March 31, 2014 | -0.91 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -0.0609 |
| Pfizer Inc. | -0.0435 |
| Gossamer Bio, Inc. | -6.124 |
| Legend Biotech Corp. | 0.1716 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.143M |
| Revenue (Quarterly) | 1.014M |
| Total Expenses (Quarterly) | 6.157M |
| Enterprise Value | 796.40M |
| Gross Profit Margin (Quarterly) | 98.92% |
| Profit Margin (Quarterly) | -507.2% |
| Earnings Yield | 18.30% |
| Operating Earnings Yield | 17.73% |
| Normalized Earnings Yield | 18.17 |